In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli.

We investigated the activity of benzoxazinorifamycin (KRM-1648) against several drug-susceptible and multidrug-resistant strains of tubercle bacilli. Since KRM-1648 is a rifamycin derivative, we included some strains of Mycobacterium tuberculosis resistant to rifampin (RIF) among the multidrug-resis...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Luna-Herrera, J, Reddy, M V, Gangadharam, P R
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1995
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162557/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7726512/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.2.440
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!